VKORC1 deficiency in mice causes early postnatal lethality due to severe bleeding

Summary

Vitamin K hydroquinone is oxidised to the epoxide form (K>O) during vitamin K-dependent posttranslational γ-glutamyl carboxylation resulting in biological active so called vitamin K-dependent proteins. In turn, K>O is reduced by the enzyme VKORC1 (vitamin K epoxide reductase complex component 1) to complete the vitamin K cycle. To investigate the biological role of VKORC1 in vivo, we generated VKORC1 knockout mice. Homozygous VKORC1-deficient mice developed normally until birth. Within 2–20 days after birth, the knockout mice died due to extensive, predominantly intracerebral haemorrhage. Bleeding resulted from a severe deficiency of γ-carboxylated clotting factors. This lethal phenotype could be rescued by oral administration of vitamin K. Additionally, morphometric analysis of the limbs in VKORC1-deficient animals revealed reduced length of bone calcification relative to wild-type control mice. The observed phenotype of VKORC1 knockout mice excludes the existence of other enzymes with VKOR activity that can substitute to supply vitamin K hydroquinone required for maturation of blood clotting factors. Thus, our study underscores the essential role of VKORC1 in vitamin K-dependent γ-glutamyl carboxylation.

Keywords

VKORC1 - knockout mouse - bleeding phenotype - bone pheno-type - vitamin K

• References

• 1 Bell RG, Matschiner JT. Vitamin K activity of phylloquinone oxide. Arch Biochem Biophys 1970; 141: 473-476.
• 2 Rost S. et al. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 2004; 427: 537-541.
• 3 Li T. et al. Identification of the gene for vitamin K epoxide reductase. Nature 2004; 427: 541-544.
• 4 Rieder MJ. et al. Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J Med 2005; 352: 2285-2293.
• 5 Geisen C. et al. VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation. Thromb Haemost 2005; 94: 773-779.
• 6 Oldenburg J. et al. VKORC1: molecular target of coumarins. J Thromb Haemost 2007; 5 (Suppl. 01) 1-6.
• 7 Dam H. The antihaemorrhagic vitamin of the chick. Biochem J 1935; 29: 1273-1285.
• 8 Kulman JD. et al. Identification of two novel trans-membrane gamma-carboxyglutamic acid proteins expressed broadly in fetal and adult tissues. Proc Natl Acad Sci USA 2001; 98: 1370-1375.
• 9 Bugel S. Vitamin K and bone health. Proc Nutr Soc 2003; 62: 839-843.
• 10 Sun WY. et al. Prothrombin deficiency results in embryonic and neonatal lethality in mice. Proc Natl Acad Sci USA 1998; 95: 7597-7602.
• 11 Xue J. et al. Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice. Proc Natl Acad Sci USA 1998; 95: 7603-7607.
• 12 Rosen ED. et al. Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. Nature 1997; 390: 290-294.
• 13 Wang L. et al. A factor IX-deficient mouse model for hemophilia B gene therapy. Proc Natl Acad Sci USA 1997; 94: 11563-11566.
• 14 Dewerchin M. et al. Blood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice. Thromb Haemost 2000; 83: 185-190.
• 15 Zhu A. et al. Fatal hemorrhage in mice lacking gamma-glutamyl carboxylase. Blood 2007; 109: 5270-5275.
• 16 Oldenburg J. et al. Congenital deficiency of vitamin K dependent coagulation factors in two families presents as a genetic defect of the vitamin K-epoxidereductase-complex. Thromb Haemost 2000; 84: 937-941.
• 17 Marchetti G. et al. Vitamin K-induced modification of coagulation phenotype in VKORC1 homozygous deficiency. J Thromb Haemost 2008; 6: 797-803.
• 18 Eggan K. et al. Male and female mice derived from the same embryonic stem cell clone by tetraploid embryo complementation. Nat Biotechnol 2002; 20: 455-459.
• 19 Hogan B. et al. Manipulating the mouse embryo. Cold Spring Harbor Laboratory Press; 1987
• 20 Sambrook J. et al. Molecular cloning. A laboratory manual. 2nd ed. Cold Spring Harbor Laboratory Press; New York: 1989
• 21 Schwenk F. et al. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res 1995; 23: 5080-5081.
• 22 Canfield LM. et al. Vitamin K in colostrum and mature human milk over the lactation period--a cross-sectional study. Am J Clin Nutr 1991; 53: 730-735.
• 23 Greer FR. et al. Improving the vitamin K status of breastfeeding infants with maternal vitamin K supplements. Pediatrics 1997; 99: 88-92.
• 24 Pauli RM. et al. Association of congenital deficiency of multiple vitamin K-dependent coagulation factors and the phenotype of the warfarin embryopathy: Clues to the mechanism of teratogenicity of coumarin derivatives. Am J Hum Genet 1987; 41: 566-583.
• 25 Howe AM. et al. Severe cervical dysplasia and nasal cartilage calcification following prenatal warfarin exposure. Am J Med Genet 1997; 71: 391-396.
• 26 Howe AM, Webster WS. The warfarin embryo-pathy: a rat model showing maxillonasal hypoplasia and other skeletal disturbances. Teratology 1992; 46: 379-390.
• 27 Eronick J. et al. Effects of sodium warfarin administered during pregnancy in mice. Am J Obstet Gynecol 1974; 118: 819-823.
• 28 Ducy P. et al. Increased bone formation in osteocalcin-deficient mice. Nature 1996; 382: 448-452.
• 29 Luo G. et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386: 78-81.
• 30 Price PA. et al. Primary structure of the gamma-carboxyglutamic acid-containing protein from bovine bone. Proc Natl Acad Sci USA 1976; 73: 3374-3375.
• 31 Hauschka PV. et al. Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. Proc Natl Acad Sci USA 1975; 72: 3925-3929.